anmelden
FTSE All-Share
5.795,89
PKT
+9,49
PKT
+0,16
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.05.14 | HSBC Neutral | Citigroup Corp. | |
| 30.05.14 | Lloyds Banking Group buy | Deutsche Bank AG | |
| 30.05.14 | Barclays buy | Nomura | |
| 29.05.14 | Barclays overweight | JP Morgan Chase & Co. | |
| 29.05.14 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.05.14 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 28.05.14 | Vodafone Group Neutral | Nomura | |
| 28.05.14 | London Stock Exchange (LSE) Outperform | Credit Suisse Group | |
| 28.05.14 | GSK buy | Société Générale Group S.A. (SG) | |
| 28.05.14 | GSK Neutral | UBS AG | |
| 28.05.14 | Rio Tinto buy | Deutsche Bank AG | |
| 28.05.14 | AstraZeneca Hold | Deutsche Bank AG | |
| 28.05.14 | Vodafone Group Neutral | Goldman Sachs Group Inc. | |
| 28.05.14 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.05.14 | GSK Underperform | BNP PARIBAS | |
| 27.05.14 | Vodafone Group buy | Citigroup Corp. | |
| 27.05.14 | AstraZeneca Sell | Société Générale Group S.A. (SG) | |
| 23.05.14 | Vodafone Group Hold | S&P Capital IQ | |
| 23.05.14 | Barclays overweight | JP Morgan Chase & Co. | |
| 23.05.14 | Unilever Halten | Independent Research GmbH | |
| 23.05.14 | HSBC Hold | Deutsche Bank AG | |
| 23.05.14 | Unilever buy | Deutsche Bank AG | |
| 23.05.14 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 23.05.14 | Lloyds Banking Group overweight | Barclays Capital | |
| 23.05.14 | London Stock Exchange (LSE) Neutral | Goldman Sachs Group Inc. | |
| 22.05.14 | Vodafone Group Halten | Independent Research GmbH | |
| 22.05.14 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 22.05.14 | BAT buy | Citigroup Corp. | |
| 21.05.14 | Rio Tinto Sell | Goldman Sachs Group Inc. | |
| 21.05.14 | Glencore Neutral | Goldman Sachs Group Inc. | |
| 21.05.14 | BP Neutral | Citigroup Corp. | |
| 21.05.14 | Shell (ex Royal Dutch Shell) Neutral | Citigroup Corp. | |
| 21.05.14 | Vodafone Group Neutral | Goldman Sachs Group Inc. | |
| 21.05.14 | Vodafone Group buy | UBS AG | |
| 21.05.14 | AstraZeneca buy | UBS AG | |
| 21.05.14 | AstraZeneca Equal weight | Barclays Capital | |
| 21.05.14 | Vodafone Group overweight | JP Morgan Chase & Co. | |
| 20.05.14 | AstraZeneca Halten | Independent Research GmbH | |
| 20.05.14 | Lloyds Banking Group buy | Deutsche Bank AG | |
| 20.05.14 | Glencore Neutral | UBS AG |
